Clinical phenotype and genetic features of 16p11.2 microdeletion-related epilepsy in children
LAI Chong-Yuan, CHEN Rui-Hua, ZHONG Chun-Lan, JI Ming-Ming, LI Bing-Fei
Center of Epilepsy Diagnosis and Treatment, Department of Pediatric Neurology, Ganzhou Maternal and Child Health Care Hospital, Ganzhou, Jiangxi 341000, China (Chen R-H, Email: crh16899@sina.cn)
Abstract:Objective To study the clinical phenotype and genetic features of 16p11.2 microdeletion-related epilepsy in children. Methods The medical data of 200 children with epilepsy who underwent a genetic analysis of epilepsy by the whole exon sequencing technology were collected retrospectively, of whom 9 children with epilepsy had 16p11.2 microdeletion. The clinical phenotype and genetic features of the 9 children with 16p11.2 microdeletion were analyzed. Results The detection rate of 16p11.2 microdeletion was 4.5% (9/200). The 9 children with 16p11.2 microdeletion were 3-10 months old. They experienced focal motor seizures with consciousness disturbance, and some of the seizures developed into generalized tonic-clonic seizures. The interictal electroencephalogram showed focal or multifocal epileptiform discharge, and all 9 children responded well to antiepileptic drugs. The 9 children had a 16p11.2 deletion fragment size of 398-906 kb, and the number of deleted genes was 23-33 which were all pathogenic mutations. The mutation was of maternal origin in 2 children, of paternal origin in 1 child, and de novo in the other children. Conclusions 16p11.2 microdeletion can be detected in some children with epilepsy. Most of the 16p11.2 microdeletion is de novo mutation and large gene fragment deletion. The onset of 16p11.2 microdeletion-related epilepsy in children is mostly within 1 year of life, and the epilepsy is drug-responsive.
LAI Chong-Yuan,CHEN Rui-Hua,ZHONG Chun-Lan et al. Clinical phenotype and genetic features of 16p11.2 microdeletion-related epilepsy in children[J]. CJCP, 2022, 24(5): 585-590.
Matsuzaki J, Berman JI, Blaskey L, et al. Abnormal auditory mismatch fields in children and adolescents with 16p11.2 deletion and 16p11.2 duplication[J]. Biol Psychiatry Cogn Neurosci Neuroimaging, 2020, 5(10): 942-950. PMID: 32033921. DOI: 10.1016/j.bpsc.2019.11.005.
Blackmon K, Thesen T, Green S, et al. Focal cortical anomalies and language impairment in 16p11.2 deletion and duplication syndrome[J]. Cereb Cortex, 2018, 28(7): 2422-2430. PMID: 28591836. DOI: 10.1093/cercor/bhx143.
Bachmann-Gagescu R, Mefford HC, Cowan C, et al. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity[J]. Genet Med, 2010, 12(10): 641-647. PMID: 20808231. DOI: 10.1097/GIM.0b013e3181ef4286.
Vlaskamp DRM, Callenbach PMC, Rump P, et al. PRRT2-related phenotypes in patients with a 16p11.2 deletion[J]. Eur J Med Genet, 2019, 62(4): 265-269. PMID: 30125676. DOI: 10.1016/j.ejmg.2018.08.002.
Kleinendorst L, van den Heuvel LM, Henneman L, et al. Who ever heard of 16p11.2 deletion syndrome? Parents' perspectives on a susceptibility copy number variation syndrome[J]. Eur J Hum Genet, 2020, 28(9): 1196-1204. PMID: 32415274. PMCID: PMC7608422. DOI: 10.1038/s41431-020-0644-6.
Kleinendorst L, Sno M, van Haelst MM. A girl with 16p11.2 deletion syndrome[J]. Ned Tijdschr Geneeskd, 2019, 163: D3441. PMID: 30945833.
Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size[J]. J Med Genet, 2010, 47(5): 332-341. PMID: 19914906. PMCID: PMC3158566. DOI: 10.1136/jmg.2009.073015.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia, 2017, 58(4): 512-521. PMID: 28276062. PMCID: PMC5386840. DOI: 10.1111/epi.13709.
Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2020, 22(2): 245-257. PMID: 31690835. PMCID: PMC7313390. DOI: 10.1038/s41436-019-0686-8.
Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia, 2017, 58(4): 522-530. PMID: 28276060. DOI: 10.1111/epi.13670.
Bassuk AG, Geraghty E, Wu S, et al. Deletions of 16p11.2 and 19p13.2 in a family with intellectual disability and generalized epilepsy[J]. Am J Med Genet A, 2013, 161A(7): 1722-1725. PMID: 23686817. PMCID: PMC4169108. DOI: 10.1002/ajmg.a.35946.
Weber A, K?hler A, Hahn A, et al. Benign infantile convulsions (IC) and subsequent paroxysmal kinesigenic dyskinesia (PKD) in a patient with 16p11.2 microdeletion syndrome[J]. Neurogenetics, 2013, 14(3-4): 251-253. PMID: 24100940. DOI: 10.1007/s10048-013-0376-7.
Calame DJ, Xiao J, Khan MM, et al. Presynaptic PRRT2 deficiency causes cerebellar dysfunction and paroxysmal kinesigenic dyskinesia[J]. Neuroscience, 2020, 448: 272-286. PMID: 32891704. DOI: 10.1016/j.neuroscience.2020.08.034.